Skip to main content
Log in

MCEF, the newest member of the AF4 family of transcription factors involved in leukemia, is a positive transcription elongation factor-b-associated protein

  • Original Paper
  • Published:
Journal of Biomedical Science

Abstract

Positive transcription elongation factor-b (P-TEFb) contains CDK9 and cyclin T1. P-TEFb was affinity purified from a stably transfected cell line that expresses epitopetagged CDK9, and proteins that appeared to be specifically bound were sequenced. In addition to CDK9, previously identified isoforms of cyclin T (including T1, T2A and T2B), HSP90 and CDC37, this analysis identified a novel protein named MCEF. Cloning of its cognate cDNA revealed that MCEF is the newest member of the AF4 family of transcription factors involved in acute lymphoblastic leukemia. MCEF RNA was expressed in all human tissues examined, and antisera directed against recombinant MCEF specifically immunoprecipitated P-TEFb. Ectopic expression of MCEF did not activate HIV-1 replication, and tethering of MCEF to a promoter did not activate transcription.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Buchner J. Hsp90 & Co. — a holding for folding. Trends Biochem Sci 24:136–141;1999.

    Google Scholar 

  2. Chen D, Zhou Q. Tat activates human immunodeficiency virus type 1 transcriptional elongation independent of TFIIH kinase. Mol Cell Biol 19:2863–2871;1999.

    Google Scholar 

  3. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475–1489;1983.

    Google Scholar 

  4. Estable MC, Bell B, Hirst M, Sadowski I. Naturally occurring human immunodeficiency virus type 1 long terminal repeats have a frequently observed duplication that binds RBF-2 and represses transcription. J Virol 72:6465–6474;1998.

    Google Scholar 

  5. Estable MC, Bell B, Merzouki A, Montaner J, O'Shaughnessy MV, Sadowski IJ. Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity. J Virol 70:4053–4062;1996.

    Google Scholar 

  6. Estable MC, Hirst M, Bell B, O'Shaughnessy MV, Sadowski I. Purification of RBF-2, a transcription factor with specificity for the most conserved cis-element of naturally occurring HIV-1 LTRs. J Biomed Sci 6:320–332;1999.

    Google Scholar 

  7. Estable MC, Merzouki A, Arella M, Sadowski IJ. Distinct clustering of HIV type 1 sequences derived from injection versus noninjection drug users in Vancouver, Canada. AIDS Res Hum Retroviruses 14:917–919;1998.

    Google Scholar 

  8. Garber ME, Mayall TP, Suess EM, Meisenhelder J, Thompson NE, Jones KA. CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA. Mol Cell Biol 20:6958–6969;2000.

    Google Scholar 

  9. Gecz J, Bielby S, Sutherland GR, Mulley JC. Gene structure and subcellular localization of FMR2, a member of a new family of putative transcription activators. Genomics 44:201–213;1997.

    Google Scholar 

  10. Grana X, De Luca A, Sang N, Fu Y, Claudio PP, Rosenblatt J, Morgan DO, Giordano A. PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro. Proc Natl Acad Sci USA 91:3834–3838;1994.

    Google Scholar 

  11. Herrmann CH, Rice AP. Specific interaction of the human immunodeficiency virus Tat proteins with a cellular protein kinase. Virology 197:601–608;1993.

    Google Scholar 

  12. Herrmann CH, Rice AP. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: Candidate for a Tat cofactor. J Virol 69:1612–1620;1995.

    Google Scholar 

  13. Isel C, Karn J. Direct evidence that HIV-1 Tat stimulates RNA polymerase II carboxyl-terminal domain hyperphosphorylation during transcriptional elongation. J Mol Biol 290:929–941;1999.

    Google Scholar 

  14. Ivanov D, Kwak YT, Guo J, Gaynor RB. Domains in the SPT5 protein that modulate its transcriptional regulatory properties. Mol Cell Biol 20:2970–2983;2000.

    Google Scholar 

  15. Jones KA. Taking a new TAK on tat transactivation. Genes Dev 11:2593–2599;1997.

    Google Scholar 

  16. Karn J. Tackling Tat. J Mol Biol 293:235–254;1999.

    Google Scholar 

  17. Kim JB, Sharp PA. Positive transcription elongation factor B phosphorylates hSPT5 and RNA polymerase II carboxyl-terminal domain independently of cyclin-dependent kinase-activating kinase. J Biol Chem 276:12317–12323;2001.

    Google Scholar 

  18. Kozak M. Initiation of translation in prokaryotes and eukaryotes. Gene 234:187–208;1999.

    Google Scholar 

  19. Mancebo HS, Lee G, Flygare J, Tomassini J, Luu P, Zhu Y, Peng J, Blau C, Hazuda D, Price D, Flores O. P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev 11:2633–2644;1997.

    Google Scholar 

  20. Marshall NF, Peng J, Xie Z, Price DH. Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase. J Biol Chem 271:27176–27183;1996.

    Google Scholar 

  21. Marshall NF, Price DH. Control of formation of two distinct classes of RNA polymerase II elongation complexes. Mol Cell Biol 12:2078–2090;1992.

    Google Scholar 

  22. Marshall NF, Price DH. Purification of P-TEFb, a transcription factor required for the transition into productive elongation. J Biol Chem 270:12335–12338;1995.

    Google Scholar 

  23. Naghavi MH, Estable MC, Schwartz S, Roeder RG, Vahlne A. Upstream stimulating factor affects human immunodeficiency virus type 1 (HIV-1) long terminal repeat-directed transcription in a cell-specific manner, independently of the HIV-1 subtype and the core-negative regulatory element. J Gen Virol 82:547–559;2001.

    Google Scholar 

  24. Naghavi MH, Schwartz S, Sonnerborg A, Vahlne A. Long terminal repeat promoter/enhancer activity of different subtypes of HIV type 1. AIDS Res Hum Retroviruses 15:1293–1303;1999.

    Google Scholar 

  25. Napolitano G, Majello B, Licciardo P, Giordano A, Lania L. Transcriptional activity of positive transcription elongation factor b kinase in vivo requires the C-terminal domain of RNA polymerase II. Gene 254:139–145;2000.

    Google Scholar 

  26. O'Keeffe B, Fong Y, Chen D, Zhou S, Zhou Q. Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription. J Biol Chem 275:279–287;2000.

    Google Scholar 

  27. Parada CA, Roeder RG. A novel RNA polymerase II-containing complex potentiates Tatenhanced HIV-1 transcription. EMBO J 18:3688–3701;1999.

    Google Scholar 

  28. Peng J, Marshall NF, Price DH. Identification of a cyclin subunit required for the function ofDrosophila P-TEFb. J Biol Chem 273:13855–13860;1998.

    Google Scholar 

  29. Peng J, Zhu Y, Milton JT, Price DH. Identification of multiple cyclin subunits of human P-TEFb. Genes Dev 12:755–762;1998.

    Google Scholar 

  30. Ping YH, Rana TM. Tat-associated kinase (P-TEFb): A component of transcription preinitiation and elongation complexes. J Biol Chem 274:7399–7404;1999.

    Google Scholar 

  31. Prasad R, Yano T, Sorio C, Nakamura T, Rallapalli R, Gu Y, Leshkowitz D, Croce CM, Canaani E. Domains with transcriptional regulatory activity within the ALL1 and AF4 proteins involved in acute leukemia. Proc Natl Acad Sci USA 92:12160–12164;1995.

    Google Scholar 

  32. Price DH. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol Cell Biol 20:2629–2634;2000.

    Google Scholar 

  33. Shilatifard A, Lane WS, Jackson KW, Conaway RC, Conaway JW. An RNA polymerase II elongation factor encoded by the human ELL gene. Science 271:1873–1876;1996.

    Google Scholar 

  34. Taki T, Kano H, Taniwaki M, Sako M, Yanagisawa M, Hayashi Y. AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23). Proc Natl Acad Sci USA 96:14535–14540;1999.

    Google Scholar 

  35. Wada T, Takagi T, Yamaguchi Y, Ferdous A, Imai T, Hirose S, Sugimoto S, Yano K, Hartzog GA, Winston F, Buratowski S, Handa H. DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Genes Dev 12:343–356;1998.

    Google Scholar 

  36. Wei P, Garber ME, Fang SM, Fischer WH, Jones KA. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92:451–462;1998.

    Google Scholar 

  37. Xiao H, Palhan V, Yang Y, Roeder RG. TIP30 has an intrinsic kinase activity required for upregulation of a subset of apoptotic genes. EMBO J 19:956–963;2000.

    Google Scholar 

  38. Yamaguchi Y, Takagi T, Wada T, Yano K, Furuya A, Sugimoto S, Hasegawa J, Handa H. NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell 97:41–51;1999.

    Google Scholar 

  39. Yamaguchi Y, Wada T, Handa H. Interplay between positive and negative elongation factors: Drawing a new view of DRB. Genes Cells 3:9–15;1998.

    Google Scholar 

  40. Yamaguchi Y, Wada T, Watanabe D, Takagi T, Hasegawa J, Handa H. Structure and function of the human transcription elongation factor DSIF. J Biol Chem 274:8085–8092;1999.

    Google Scholar 

  41. Yang X, Gold MO, Tang DN, Lewis DE, Aguilar-Cordova E, Rice AP, Herrmann CH. TAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines. Proc Natl Acad Sci USA 94:12331–12336;1997.

    Google Scholar 

  42. Yang X, Herrmann CH, Rice AP. The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function. J Virol 70:4576–4584;1996.

    Google Scholar 

  43. Zhou M, Halanski MA, Radonovich MF, Kashanchi F, Peng J, Price DH, Brady JN. Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription. Mol Cell Biol 20:5077–5086;2000.

    Google Scholar 

  44. Zhou Q, Chen D, Pierstorff E, Luo K. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages. EMBO J 17:3681–3691;1998.

    Google Scholar 

  45. Zhu Y, Pe'ery T, Peng J, Ramanathan Y, Marshall N, Marshall T, Amendt B, Mathews MB, Price DH. Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev 11:2622–2632;1997.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Estable, M.C., Naghavi, M.H., Kato, H. et al. MCEF, the newest member of the AF4 family of transcription factors involved in leukemia, is a positive transcription elongation factor-b-associated protein. J Biomed Sci 9, 234–245 (2002). https://doi.org/10.1007/BF02256070

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02256070

Key Words

Navigation